{"id":"W2143681410","doi":"10.1038/bjc.2011.516","title":"Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer","year":2012,"lang":"en","type":"review","venue":"British Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Terry Fox Foundation; Boehringer Ingelheim","keywords":"Trastuzumab; Lapatinib; Medicine; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Bevacizumab; Adjuvant; Cancer; Cancer research; Chemotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004799423,0.0006413669,0.00140547,0.001814058,0.0001994304,0.0008162265,0.0007417416,0.0009071494,0.002669055],"category_scores_gemma":[0.0004011226,0.0002022551,0.0004057416,0.001596552,0.0003827886,0.001088545,0.0005405739,0.001733501,0.001512263],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005369866,"about_ca_system_score_gemma":0.0005117233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006565643,"about_ca_topic_score_gemma":0.001678173,"domain_scores_codex":[0.999856,0.00003178397,0.00001908346,0.00002073676,0.00005547274,0.0000169526],"domain_scores_gemma":[0.9998757,0.00005798276,0.00002025501,0.000004009611,0.00002688902,0.00001507943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000111194,0.00009994348,0.0001109873,0.01014288,0.0000806793,0.0002964282,0.00006072252,0.000396233,0.002012747,0.002894084,0.01832899,0.965465],"study_design_scores_gemma":[0.00006316381,0.0001736592,0.0008049516,0.002903171,0.00009390651,0.002023205,0.00005422457,0.0001285158,0.0005970721,0.002101804,0.9910395,0.00001692322],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001347706,0.9990404,0.00006058035,0.0001503922,0.00007725295,0.000003181405,0.000006929642,0.000003412938,0.0005230767],"genre_scores_gemma":[0.0008155997,0.9983589,0.0001028662,0.000153211,0.0001004887,0.000004724625,0.00001686904,9.831421e-7,0.0004463006],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002669055,"threshold_uncertainty_score":0.008928895,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0989027358661728,"score_gpt":0.4448493664120509,"score_spread":0.3459466305458781,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}